1-3 of 3
Ernest Medina, B.S.
Close
Sort by
Journal Articles

Targeting Pim Kinase Activity with the Novel Small Molecule Inhibitor SGI-1776 Significantly Augments the Efficacy of Cytarabine In Models of Acute Myeloid Leukemia

Kevin R Kelly, MD, Kelli Oberheu, B.S., Ernest Medina, B.S., Claudia M Espitia, MS, Devalingam Mahalingam, MD, PhD, Pietro Taverna, PhD, Gavin S. Choy, PharmD, MBA, Steffan T Nawrocki, PhD, Francis J. Giles, MB, MD, FRCPI, FRCPath, Jennifer S Carew, PhD
Journal: Blood
Blood (2010) 116 (21): 3253.
https://doi.org/10.1182/blood.V116.21.3253.3253
Published: 2010
Journal Articles

The Novel Orally Active Aurora A Kinase Inhibitor MLN8237 Is Highly Active in Preclinical Models of Acute Myeloid Leukemia and Significantly Increases the Efficacy of Cytarabine.

Kevin R. Kelly, MD, Ronan T. Swords, M.D., Devalingam Mahalingam, M.D., Steffan T. Nawrocki, PhD, Ernest Medina, B.S., Sabrina Smith, Swaminathan Padmanabhan, MD, MBBS, Jeffrey Ecsedy, Mary R Cahill, FRCPI, FRCPath, Francis J. Giles, MB, MD, FRCPI, FRCPath, Jennifer S. Carew, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2087.
https://doi.org/10.1182/blood.V114.22.2087.2087
Published: 2009
Journal Articles

The Aurora Kinase Inhibitor MLN8237 Has Potent Anticancer Activity in CML and Ph+ ALL Models and Significantly Increases the Efficacy of Nilotinib

Steffan T. Nawrocki, Ph.D., Ernest Medina, B.S., Sabrina Smith, B.S., Ronan Swords, M.D., Kevin Kelly, M.D., Swaminathan Padmanabhan, M.D., Jeffrey Ecsedy, Ph.D., Francis J Giles, M.D., Jennifer Carew, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3198.
https://doi.org/10.1182/blood.V112.11.3198.3198
Published: 2008